101
Views
9
CrossRef citations to date
0
Altmetric
Review

Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension

Pages 1237-1248 | Published online: 05 Dec 2008

References

  • BallKJWilliamsPAStumpeKO2001Relative efficacy of an angiotensin II antagonist compared with other antihypertensive agents. Olmesartan medoxomil versus antihypertensivesJ Hypertens Suppl19S495611451215
  • BarriosVBoccanelliAEwaldS2007Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST StudyClin Drug Investig275458
  • BenzJRBlackHRGraffA1998Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with mono-therapyJ Hum Hypertens1286169883710
  • BrunnerHRLaeisP2003Clinical efficacy of olmesartan medoxomilJ Hypertens Suppl21Suppl 2S43612929907
  • CampbellMSonkodiSSoucekM2001A candesartan cilexetil/hydrochlorothiazide combination tablet provides effective blood pressure control in hypertensive patients inadequately controlled on monotherapyClin Exp Hypertens233455511349825
  • ChobanianAVBakrisGLBlackHR2003The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportJAMA28925607212748199
  • ChrysantSGWeberMAWangAC2004Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazideAm J Hypertens17252915001200
  • CushmanWCFordCECutlerJA2002Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)J Clin Hypertens (Greenwich)439340412461301
  • DahlofBDevereuxRBKjeldsenSE2002Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololLancet359995100311937178
  • Daiichi Sankyo, Data on file.
  • Daiichi Sankyo, Integrated Summary of Efficacy. Data on file.
  • Daiichi Sankyo, Integrated Summary of Safety. Data on file.
  • de la SierraAGil-extremeraBCalvoC2004Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patientsJ Hum Hypertens182152214973517
  • FabiaMJAbdillaNOltraR2007Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoringJ Hypertens2513273617563549
  • HanssonLZanchettiAMCarruthersSG1998Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupLancet3511755629635947
  • KereiakesDJNeutelJMPunziHA2007Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylateAm J Cardiovasc Drugs73617217953475
  • KocharMGuthrieRTriscariJ1999Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertensionAm J Hypertens1279780510480473
  • LacourciereYGil-ExtremeraBMuellerO2003Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertensionInt J Clin Pract57273912800457
  • LacourciereYPoirierL2003Antihypertensive effects of two fixed-dose combinations of losartan and hydrochlorothiazide versus hydrochlorothiazide monotherapy in subjects with ambulatory systolic hypertensionAm J Hypertens1610364214643578
  • LacourciereYTytusRO’KeefeD2001Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapyJ Hum Hypertens157637011687919
  • LawMRWaldNJMorrisJK2003Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trialsBMJ326142712829555
  • LewingtonSClarkeRQizilbashN2002Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesLancet36019031312493255
  • ManciaGDe BackerGDominiczakA2007Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens2511058717563527
  • NeutelJMLittlejohnTWChrysantSG2005Telmisartan/hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertensionHypertens Res285556316335883
  • NeutelJMSmithDHSilfaniTN2006Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertensionJ Hum Hypertens202556216397514
  • NeutelJMSmithDHWeberMA2004Use of an olmesartan medoxomil-based treatment algorithm for hypertension controlJ Clin Hypertens (Greenwich)61687415073470
  • O’BrienEAsmarRBeilinL2003European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurementJ Hypertens218214812714851
  • PickeringTGJamesGDBoddieC1988How common is white coat hypertension?JAMA25922583336140
  • PsatyBMLumleyTFurbergCD2003Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysisJAMA28925344412759325
  • PsatyBMSmithNLSiscovickDS1997Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysisJAMA277739459042847
  • PuchlerKLaeisPStumpeKO2001Blood pressure response, but not adverse event incidence, correlates with dose of angiotensin II antagonistJ Hypertens Suppl19S41811451214
  • RamCV2004Antihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: a review of the factorial-design studiesJ Clin Hypertens (Greenwich)65697715470286
  • SalernoCMDemopoulosLMukherjeeR2004Combination angiotensin receptor blocker/hydrochlorothiazide as initial therapy in the treatment of patients with severe hypertensionJ Clin Hypertens (Greenwich)66142015538094
  • SellinLStegbauerJLaeisP2005Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertensionJ Hypertens2320839216208152
  • StumpeKOLudwigM2002Antihypertensive efficacy of olmesartan compared with other antihypertensive drugsJ Hum Hypertens16Suppl 2S244811967729
  • WaeberBAschwandenRSadeckyL2001Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan aloneJ Hypertens19209710411677377
  • WatanabeLAWeiMSunN2006Effect on blood pressure control of switching from valsartan monotherapy to losartan/hydrochlorothiazide in Asian patients with hypertension: results of a multicentre open-label trialCurr Med Res Opin2219556417022855
  • WhiteWBGilesTBakrisGL2006Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care settingAm Heart J1511768416368314
  • WhitworthJA20032003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertensionJ Hypertens2119839214597836